siRNA封闭IGFIR蛋白表达治疗肝癌的实验研究
|
摘要
原发性肝癌是常见的消化系统恶性肿瘤,约占消化系统肿瘤的20%以上,其中肝细胞肝癌约占90%,其生物学特征为易复发、转移、预后差、死亡率高。尽管目前原发性肝癌的治疗方案(手术切除、介入治疗、生物治疗、激光及微波治疗等)日趋完善,但仍难以取得令人满意的疗效,患者生存期极短。因此研究肝癌的发病机理以及探讨新的可行的治疗方案具有极其重要的临庆意义。
随着肿瘤学领域中基础研究的不断深入,人们发现在肿瘤组织中存在一些生长因子及其受体过表达的现象,为探讨肿瘤的发生机制奠定了基础。胰岛素样生长因子Ⅰ受体蛋白(IGFIR)是一种重要的促生长因子,它参与肿瘤细胞的生长、分化、转移、增殖等多方面的过程。因此IGFIR可能与肝癌的发生、发展有重要的相关性联系。
目前,国内外针对IGFIR基因表达与肝细胞癌分化程度、生长方式、临床特点及转移活性的关系尚未进行深入系统的研究。针对肝癌的胰岛素样生长因子Ⅰ受体蛋白(IGFIR)利用小干扰RNA基因治疗尚无报道。本课题从三个角度进行了系统研究:①肝癌组织IGFIR基因表达与肝癌恶性程度、临床特点、转移活性的相关性和在肝癌细胞中的表达。②采用脂质体体外转染针对IGFIR的小干扰RNA,并建立稳定株观察转染后肿瘤细胞在体外的生长情况及产生的可能机制。③IGFIR小干扰RNA转染后肿瘤细胞体内生长情况观察。
结果将为探讨以IGFIR为优选靶并结合小干扰RNA进行基因治疗,阻止肿瘤的发生和发展,提高生存率,延长生存期奠定理论基础。
第一部分IGFIR在肝癌组织、肝癌细胞系中的表达及意义
本研究对24对肝细胞癌(HCC),4例正常肝组织、4例胎肝组织以及14株肝癌细胞株用RT-PCR反应、免疫组化法、Western-blot分别检测IGFIRmRNA表达和蛋白表达的情况;分析肝癌IGFIR基因表达与肿瘤分期、转移等临床指标之间的关系。
1通过RT-PCR方法检测24对人肝细胞癌、4例正常肝脏组织和4例胎肝组织IGFIRmRNA表达水平:发现肝癌组织IGFIRmRNA的表达明显高于癌旁组织,其中有20对下调,所占比率高达63%(P<0.01)。其中有7对接近有和无的关系。正常肝和胎肝中没表达。此外发现:瘤栓组
Liver cancer is one of the common types of gastrointestinal tumors with poor prognosis metastasis and high mortality in which hepatocellular carcinoma(HCC)accounts for about 95%. Although the different available multi-modalities of therapies,including radical surgical operation、intervention therapy、laser therapy et al,have currently been used in the treatment for liver cancer,the prognosis of liver cancer has not been markedly improved. Therefore, it has an important clinic significance to study on the mechanism of the development and progression of liver cancer and the new strategies for the treatment of liver cancer with the molecular biology. With the development of the basic research on oncological fields, it was found that many tumors have the over expression in growth factors& their receptors, and progression of tumors depends on angiogenesis. The insulin-like growth factor (IGFIR)is an important factor which elicits the angiogensis in tumors. It takes an important role in the growth、differentiation、metastasis、proliferation of tumors. so IGFIR is considered to have key roles in the development of HCC. By now,the systemic researches on the relationship between the expression of IGFIR and histopathologic type, metastasis activity、angiogenesis of HCC have not been reported. And there are also no reports on gene therapy against angiogeneis of liver cancer. This study contains three parts of work: The first, the relationships between the expression of IGFIR in HCC and the tumor grade,tumor metastasis,angiogenesis of liver cancer. The second the inhibitory effect of IGFIR small interfere RNA on the growth of 7721 hepatocellular cell line (7721 cancer hepatocytes)in vivo. The third,the inhibitory effect of IGFIR small interfere RNA on 7721 cell in nude mouse.
Part I: Study on the expression of IGFIR and its relationship to metastasis activity and angiogenesis of human HCC
1 Expression of IGFIR gene in human HCC and normal liver tissue. The gene expression of IGFIR in 24 pair human HCCs and 4 normal liver were studied by RT-PCR method. The expressive rates of HCCs and normal tissue were 63% and 0% respectively. 7 paired samples are yes or no. Moreover, The levels of IGFIR mRNA (IGFIR mRNA/?-actin mRNA) were 105.9±6.8 in embolus, 120.3±6.3 in metastasis respectively. The difference between them are significant. The expression levels of IGFIR mRNA were positively correlated to pathologic grades、embolus and
随着肿瘤学领域中基础研究的不断深入,人们发现在肿瘤组织中存在一些生长因子及其受体过表达的现象,为探讨肿瘤的发生机制奠定了基础。胰岛素样生长因子Ⅰ受体蛋白(IGFIR)是一种重要的促生长因子,它参与肿瘤细胞的生长、分化、转移、增殖等多方面的过程。因此IGFIR可能与肝癌的发生、发展有重要的相关性联系。
目前,国内外针对IGFIR基因表达与肝细胞癌分化程度、生长方式、临床特点及转移活性的关系尚未进行深入系统的研究。针对肝癌的胰岛素样生长因子Ⅰ受体蛋白(IGFIR)利用小干扰RNA基因治疗尚无报道。本课题从三个角度进行了系统研究:①肝癌组织IGFIR基因表达与肝癌恶性程度、临床特点、转移活性的相关性和在肝癌细胞中的表达。②采用脂质体体外转染针对IGFIR的小干扰RNA,并建立稳定株观察转染后肿瘤细胞在体外的生长情况及产生的可能机制。③IGFIR小干扰RNA转染后肿瘤细胞体内生长情况观察。
结果将为探讨以IGFIR为优选靶并结合小干扰RNA进行基因治疗,阻止肿瘤的发生和发展,提高生存率,延长生存期奠定理论基础。
第一部分IGFIR在肝癌组织、肝癌细胞系中的表达及意义
本研究对24对肝细胞癌(HCC),4例正常肝组织、4例胎肝组织以及14株肝癌细胞株用RT-PCR反应、免疫组化法、Western-blot分别检测IGFIRmRNA表达和蛋白表达的情况;分析肝癌IGFIR基因表达与肿瘤分期、转移等临床指标之间的关系。
1通过RT-PCR方法检测24对人肝细胞癌、4例正常肝脏组织和4例胎肝组织IGFIRmRNA表达水平:发现肝癌组织IGFIRmRNA的表达明显高于癌旁组织,其中有20对下调,所占比率高达63%(P<0.01)。其中有7对接近有和无的关系。正常肝和胎肝中没表达。此外发现:瘤栓组
Liver cancer is one of the common types of gastrointestinal tumors with poor prognosis metastasis and high mortality in which hepatocellular carcinoma(HCC)accounts for about 95%. Although the different available multi-modalities of therapies,including radical surgical operation、intervention therapy、laser therapy et al,have currently been used in the treatment for liver cancer,the prognosis of liver cancer has not been markedly improved. Therefore, it has an important clinic significance to study on the mechanism of the development and progression of liver cancer and the new strategies for the treatment of liver cancer with the molecular biology. With the development of the basic research on oncological fields, it was found that many tumors have the over expression in growth factors& their receptors, and progression of tumors depends on angiogenesis. The insulin-like growth factor (IGFIR)is an important factor which elicits the angiogensis in tumors. It takes an important role in the growth、differentiation、metastasis、proliferation of tumors. so IGFIR is considered to have key roles in the development of HCC. By now,the systemic researches on the relationship between the expression of IGFIR and histopathologic type, metastasis activity、angiogenesis of HCC have not been reported. And there are also no reports on gene therapy against angiogeneis of liver cancer. This study contains three parts of work: The first, the relationships between the expression of IGFIR in HCC and the tumor grade,tumor metastasis,angiogenesis of liver cancer. The second the inhibitory effect of IGFIR small interfere RNA on the growth of 7721 hepatocellular cell line (7721 cancer hepatocytes)in vivo. The third,the inhibitory effect of IGFIR small interfere RNA on 7721 cell in nude mouse.
Part I: Study on the expression of IGFIR and its relationship to metastasis activity and angiogenesis of human HCC
1 Expression of IGFIR gene in human HCC and normal liver tissue. The gene expression of IGFIR in 24 pair human HCCs and 4 normal liver were studied by RT-PCR method. The expressive rates of HCCs and normal tissue were 63% and 0% respectively. 7 paired samples are yes or no. Moreover, The levels of IGFIR mRNA (IGFIR mRNA/?-actin mRNA) were 105.9±6.8 in embolus, 120.3±6.3 in metastasis respectively. The difference between them are significant. The expression levels of IGFIR mRNA were positively correlated to pathologic grades、embolus and
引文
1 Tsuzuki T,Sugioka A,Ueda M. Hepatic resection for hepatoce Uular carcinoma[ J ].Surgery, 1990 ,107 :511.
2 Paquet K-J,Koussouris P,1VErcado MA,et al. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma :a prospective study[ J ] . Br J Surgrey ,1 991 ,78 :459.
3 France D,Capussotti L,Smadja C,et al . Resection of hepatocellular carcinoma : results in 72 European patients with cirrhosia[ J ] . Gastroenterrology,1990,98:733.
4 LeRoith D, wemer H, Beimer-Johonson, et al. Molecular and cellullar aspects of the insulin-like growth fator 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
5 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
6 Valentinis B, Baserga R. IGFIReceptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
7 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ]. Cancer Res, 2002 , 62 (10) :2942 -2950.
8 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
9 Bermont L, Lamielle F, Fauconnet S,et aL Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma ceils [ J ]. lnt J Cancer, 2000,85(1) :117 -
123.
10 Dunn SE ,Torres JV , Oh JS, et al.Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein kinase [ J ]. Cancer Res,2001 ,61(4) :1367 - 1374.
11 Dunn SE, Ehrlich M, Sharp NJ, e tal. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer[J ]. Cancer Res,I998,58(15) :3353 -3361.
12 Fire A, et al. Potent and specific genetic interference by double-stranded RNA in Gaenorhabditis elegans. Nature, 1998, 391:806
1 Colleoni M Gaion F, Liessi C; et al. Medical treatment of hepatocellular carcinoma any progress? Tumri 1994;80: 315-26。
2 LeRoith D, wemer H, Beimer-Johonson, et al. Molecular and cellullar aspects of the insulin-like growth fator 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
3 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
4 Valentinis B, Baserga R. IGFI receptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
5 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ]. Cancer Res, 2002 , 62 (10) :2942-2950.
6 Dal1e S, IMMaura, Rose DW , et al . Insulin induces heterologous desensutuzation of G-protein-coupled recpter and insulin like growth factor 1 signaling by downregulating bets-arrestin-1 [J].MOL Cell Biol,2002,22(17):6272—6285.
7 Baserga R. The insulin like growth factor 1 receptor: A Key to Tumor Growth [ J ]. Cancer Research, 1995, 55(2) :249 -252.
8 Le Roith D, weer H, Beimer Johonson, et al. Molecular and cellullar aspects of the insulin-like growth factor 1 receptor [ J ]. Endocr Rev, 1995 ,16(2) :143 -163.
9 Russell WE, Van Wyk J J, Pledger W J,et al. Inhibition of the mitogenic effect of plasma by
amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
10 Dal1e S,I MMaura,Rose DW,et al.Insulin induces heterologous desensutuzation of G-protein-coupled receptor and insulin like growth factor 1 signaling by down regulating bets-arrestin-1 [J].MOL Cell Biol,2002,22(17):6272-6285.
11 Morriohe A,DeAngelis T,Baserga R.Failure of the bovine papilloma virus to transform mouse emlbryo fibroblasts with a targeted disruption of the insulin-like growth factor 1 receptor gene [J] ,1995,69(9):5300-5303.
12 Navarro M,Barenton B,Garandel V,et al. insulin like growth factor I(IGFI)receptor over expression abo1ishes the IGF requirement for differetiation and induces a ligand -dependent transformed phenotype in C2 inducible myoblasts [J].Endocrimology,1997,138(12):5210-5219.
13 Clark RB; Howell A, Anderson E. Type I insulin - like growth factor receptor gene expression in normal human breast tissue treated with oestrngen and progesterone [J]. Br J Cancer, 1997,75(2) :251-257.
14 Wemer H, Shalita- chesner M, Abramovitch S, et al. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab, 2000,71(1 - 2) :315--320.
15 Ohlsson C, Kley N, Wemer H. et al. P53 regulates IGFI receptor expression and IGFI induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between P53 and spl [J ].Endocrinology, 1998,139 (3): 1101 - 1107.
16 Jone JI, Clemmons D. Insulin-like growth factors and their binding proteins: biological actions[ J] . Endocrine Res,1995 ,16:3.
17 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
18 Aznavoorian S, Murphy AN, Stetler stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis[J].Cancer,1993,71(4) :1368- 1383.
1 Fire A,Xu S,Montgomery MK,et al . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6 669) :806-811
2 Yu J Y, De Ruiter SL,Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(9):6 047-6 052
3 Yang D, Buchholz F,Huang Z,et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells[ J]Proc Natl Acad Sci U S A,2002,99(15) :9 942-9 947
4 Castanotto D, Li H,Rossi JJ. Functional siRNA expression from transfected PCR products[ J] . RNA,2002, 8( 11):1 454
5 Sui G,Soohoo C,Affarel B, et a1. A DNA vector based RNAi,technology to suppress gene expression in mammalian cells[ J] . Proc Natl Acad Sci U S A,2002 ,99( 8) :5 515-5 520。
6 Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by SiRNA in mammalian cells. Proc Natl Acad Sci U S A 2002;99(3):1443-8
7 Yang SH,Tutton S, Yoon K. Specific Double-Stranded RNA Interference in Undifferentiated Mouse Embryonic Stem Cells. Molecular and Cellular Biology. 2001; 21: 7807-7816
8 Xia HB,Mao QW, Paulson HL,Davidson BL. SiRNA mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002; 20:1006-1010
1 Wang D,Jing N,Lin Q. Stearylamine liposome as a new efficient reagent fox DNA transfection of eukaryotic cells .Biochem Biophy Res Co m mu,1996,226(2):450-455
2 Jaaskelainen 1, M onkkonen J, U rttiA. Oligonucleotide cationicliposome interaction. A physicochem ical study [J] Biochim Biaphus Acta, 1994, 1195(l):115-123。
3 Stamatutos L et al. Interactions of cationic lipid vesicles with negatively charged phosphollpld vesicles and biology membranes[J]Biochemistry ,1 988 ,27 :3917-3925
4 Fashnan SJ, Tousigant JD, I Aason M1, et al. Optimivation of fonnulatians and conditions for the aerosol delivery of functional cationic lipid: DNA cotnlexes. Hum Gene ner,1997;8:313-322
5 Felgner PL. Improvements in cationic liposomes for in vivo gene transfer. Hum Gene'Iher, 1996;7:
1791-1793
6 Weber M,M oller K, W elzeck M,et al. Short technical reports Effects of lip opolysaccharide on transfection efficiency in eukaryotic cells[ J]. B iotechniques, 1995, 19(6): 930-940.
7 Mac Gregor G. Optimizxing of electroporation using reporter genes. In Chang DC·Chassy BM·Saunders JAand Sowers AE (Eds). Academic Press Guide to Electroporation and Electrofusion. Academic Press.San Diego. 1992.P. 465-470.
8 J N de Wit. Structure, function and application of lactoperoxidase in natural antimicrobial system E[J].Netherlands Milk &, Dairy Journal, 1996,50:227-244
9 TEKIE W,ASTUMIAN R D,CHOCK P B .Sleective and asymmetric molecular transport across electroprorated cell membrance[J].Pore Natl Acad Sci USA. 1994 ,91 :115.
10 VAN D H,OFF MJ B,CHRISTOFFELS V M, et al .Electrotransfection with" intracellular" buffer[J].Mthods in molecular biology.1995;48 :185-97.
11 Spencer S C.Electroporation technique of DNA transfection. Applied Biochemistry and Biotechnology,1993,42(1):75-82
12 Chalfie M,Tu Y,Euskirchen G,et al. Green fluorescent protein as a marker fox gene expression[J] . Science ,1 994 ,263 :802-805
1 Fire A,Xu S,Montgomery Mc et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans,Nature,1998,391:806-811.
2 NICHOLDNR H,NICHOLDN A W.Molecular characterization Of a mouse cDNA encoding Dicer,a ribonuclease Ⅲ ortholog involved in RNA interference[J].Mann Genome,2002,13(2);67-73.
3 ELBASHIR S M,HARBORTH J,WEBER K,et a1.Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
4 SABINE B. Antisense 2 RNA regulation and RNA interference [J] . Biochemica et Biophysica Acta , 2002 ,1575:15-25.
5 SUI G,SOOHOO C ,AFFAIR E B ,et al. A DNA vector2 based RNAi technology to suppress gene expression in mammalian cells[J ] . Genetics , 2002 , 99(8),5515--5520.
6 ELBASHIR S M,HARBORTH J,WEBER K,et a1. Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
7 SlJEN T, FLEENOR J ,SIMMER F ,et al. On the role of RNA Amplification in dsRNA2 triggered gene silencing[J]. Cell ,2001 ,107(4) ,465-476.
8 LIPARDI C ,WEI Q , PATERSON B M. RNAi .as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNA[J]. Cell , 2001 , 107 (3) :297-- 307.
9 Ngo H ,Tschudi C , Gull K, et al. Double 2 stranded RNA induces mRNA degradation in Trypanosoma brucci. Proc Natl Acad Sci USA ,1998 ,95 (25) :14687-14692.
10 Montgomery MK, Xu S , Fire A. RNA as a target of double stranded RNA mediated genetic interference in Caeanorhabditis elegans. Proc Natl Aced Sci USA ,1998 , 95 (25) :15502--15507.
11 Har Dorth J , Elbashir SM , Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interferingRNAs. J Cell Sci , 2001 , 114 :4557--4565.
12 Yang D , Lu H , Erickson JW,Evidence that processed small dsRNAs may mediate sequence2specific mRNA degradation duringRNAi in Drosophila embryos. Curr Biol , 2000 , 10 (19) : 1191--1200.
13 Sabine B. Antisense RNA regulation and RNA interference. Biochem Biophys Acta , 2002 ,1575 (123) :15225.
14 Gan L , Anton KE , Masterson BA , et al. Specific interference with gene expression and gene function mediated by long double stranded RNA in neural cells. J, 2000 , 9 (18) : 1198--1208.
1 Resnicoff M.Antitum ors effects elicited by antisense-mediated down regulation of the insulin-like grow th factor I receptor. Int J Mol Med,1998, 1(5):883-888.
2 Jones JI,Clemmons DR. Insuline like growth factors and their binding proteins : biological actions( Review) [ J ].Endocr Rev ,1 995 ,16(1):3-33.
3 Chihara K,Sugimoto T.The action of GH/IGF-1/IGF-BP in osteobtasts and osteoclasts[ J] . Horm Res,1997,48:45-49.
4 Wang ZH, Ma JX,Zeng BJ, et al. Correlation of glioma cell regression with inhitition of insulin-like growth factor 1 and insulin-like growth factor-binding protein 2 expression [J] . Neuroendocrinology, 1997 , 66,203.
5 De Meyts P,Urso B,Christoffersen CT, et al .1Vbchanism of insulin and IGF 1 receptor activation and signal transduction specific :receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling( Review) [ J ]. Ann NY Acad Sci ,1995, 766( 10) :388-401
6 Khandwala HM, ACutcheon IE,Flyvbjerg A,et al .The effects of insulin like growth factors on tumorigenesis and neoplastic growth[J] Endocr Rev,2000 ,21(3) :215-244.
7 Hellawell GO,Turner GD,Davies DR, et al. Expression of the type 1 insulin like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease[J]。Cancer Res,2002,62( 10) :2942-2950
8 Moschos SJ,Mantzoros CS.The role of the IGF system in cancer: from basic to clinical studies and clinical applications[ J ] . Oncology ,2002, 63(4) :317-332
9 Sell C,Dumenil G,Deveaud C,et al. Effect of a null mutation of the insulin- like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts[ J]Al Cell Biol,1994,14( 6) :3604-3612
10 Weiner H. Dysregulation of the type IGFI Receptor as a paradigm in tumor procession[J] . Mol Cell Endocrinol,1998,141:1-5.
11 lakesley VA, Stannard BS, Kalebic T, et al. Role of the IGFIReceptor in mutagensis and tumor promotion [J] . J Endocrinol,1997, 152: 339-344.
12 Baserga R. The IGF 1 receptor in cancer research[ J].Exp Cell Res 1999 ,263(1) :1-5
13 Reiss K, Ferber A, Travali S ,et al . The protooncogene c- myb increases the expression of insulin like growth factor 1 and insulin like growth factor 1 receptor messenger RNAs by a transcriptional mechanism [J] cancer,Res,1991 ,51(21) :5997-6000
14 Li W, Hyun T,Heller M, et al . Activation of insulin- like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth[ J ] . Cancer res,2000,60(14):3909-3915
15 Long L, Rubin R, Brodt P. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor[ J ] . Exp Cell res,1998,238(1) :116-121
16 Liu X, Turbyville T,FritzA, et a 1. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in m ice. Cancer Res, 1998, 58(23):5432-5438
17 Alberts B, et al. Molecular Biology of the Cell. 4th ed. New York&London: Carland Publishing Inc, 2002
18 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
1 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
2 Aznavoorian S, Murphy AN, Stetler-stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis [J].Cancer,1993,71(4) :1368
3 Yamamoto Y, Tsutsumi Y, Mayumi T. Molecular design of bioconljugated cell adhesion peptide with a water soluble polymeric modifier for enhancement of an time tastatic effect [J ]. Curr Drug Targets, 2002,3 (2): 123
4 A rihro K, InaiK, Kurara K. Distribution of laminin, type Ⅳ collagen and fibronectin in the invasive component of breast carcinoma. Acta Pathol Jpn Dec,1993; 43: 758
5 Kibbey MC, Grant DS, Kleinman HK. Role of file SIKVAV site of laminin in plarmfion of angiogenesis and tumor growth: All in vivo Matfigel model [J ]. J Natl Cancer Inst ( Bethesda) , 1992; 84:1633- 1638.
6 DeRoock B, Pemfington ME, Stuka TC, et al. Synthetic pepfdes inhibit adhesion of human tumor cells to extracellular matrix proteins [J ]. Cancer Res, 2001 ;61(8): 3308 - 3313.
7 Carlod PS,Norman HA, Parmender P ,et al. Prostate cancer progression,metastasis,and gene expression in transgenis mice . Cancer Res ,1 997 ,57 :900-907.
8 Hee J,Sook B,Ho Y, et al. Anti-invasive activity of solie and correlates with the reduced expression of matrix met all op rote ninnase-9 (MMP-9) in HT-1080 human fibrosarcoma cells. Cancer Res,1996,56:2281-2285.
9 Allgayer H, Babic K, Beyer BC, et al. Prognostic relevance of MMP-2 (72kDconagenase IV) in gastric cancer [J]. Oncology, 1998,55(2):152.
10 Aznavoorian S,Murphy AN, Stetler Stevenson WG, et al. Molecelular suspects of tumor cell invasion and metastasis[ J] . Cancer,1993,71 :1368
11 Dunn SE ,Torres JV , Oh JS, et al. Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein
kinase [ J ]. Cancer Res,2001 ,61(4) :1367 - 1374.
12 Fujihara T,Sawada R, Hirskawa K, et al. Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis .Clin Exp Metastasis,1998,16:389-398
13 Yoong KF,Me Nab G,Hubscher SG. Vascular adhesion protein and ICAM-1 support the adhesion of tumor in filtrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J I m munol,1998,160 :3978-3988
14 Albelda S M,Buck CA. Integrins and other cell adhesion molecules. FASEB J,1996 ,17 :71-81
15 Liotta LA, Wewer U, Rao NC et al. Bio chemical mechanisms of to more invasion and metastases. Adv Exp Med Biol,1988 ,233:161
16 Pellegrinl R, Martignone S,Tagliabue E et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinoma. Breast Cancer Res Treat ,1995 ,35:195
17 Marques LA, Franco ELF, Torloni H et al. Independent prognostic value of laminin receptor expression in breast cancer survival. Cancer Res,1990,50:1 870
18 MareelM,B racke M&VanRoy F. Cancer metastasis: negative regulation by an invasion-suppressor complex. Cancer Detect P rev, 1995,19(5):451.
19 Dunn SE, Ehrlich M, Sharp NJ, et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer [J ]. Cancer Res,1998,58(15) :3353 -3361.
20 Hildebrand JD, Schaller MD,Parsons JT,et al. Identification of sequences required for the efficient localization of the focal adhesion kinase,PP 125 FAKpp,to cellular focal adhesions . J Cell Biol , 1995 ,123 :993-1005
21 Schlaepfer DD, Hanks SK, Hunter T, et al. Integrin7mediated signal transduction linked to Ras pathway by 2 binding to focal adhesion kinase . Nature , 1994 ,372 :22-29
22 Hildebrand JD, Schaller MD, Parsons- JT, et al . Paxillin,a tyrosine phosphorylated focal adhesion7associated protein,binds to the carboxyl termination domain of focal adhesion kinase . Mol Biol Cell ,1 995 ,6 :637-647
23 Frisch S M, Vuori K, Ruoslahti E,et al . Control of adhesion- dependent cell survival by focal adhesion kinase. J Cell Bio1,1996, 134:293-299
24 Owens LV, Xu LH,Craven RJ, et al 0verxpression of the focal adhesion kinase(p1 25 FAK) in invasive human tumors . Cancer Res ,1 995,55 :2752-2755
1 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis, tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995, 55(17) :3739 -3741.
2 Rubini M, Hongo A, Dambrosio C, etal. The IGF-l receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number [ J ]. Exp.Cell Res, 1997, 230 (2): 284 -292.
3 Resnicoff M, Burgaud JL, Rotman HL , et al. Correlation between apoptosis, tumorigeneisis, and levels of insulin like growth factor 1 receptors [J ]. Cancer Res,1995,55(17) :3739 -3741.
4 韩锐主编。抗癌药物研究与实验技术。人民卫生出版社 1997
5 Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J cell Biol, 1992, 119(3):493-501
6 CarbonariM,CibatiM,Fiorilli M,et al. Measurement of apoptotic cells in peripheral blood. Cytometry, 1995, 22(3):161-167
7.Inayat-Hussain, Couet SHC, Cohen GM, et al. Processing/activation of CPP32-1ike proteases is involved in transforming growth factor is induced apoptosis in rat hepatocytes. Hepatology 1997; 25:1516-1523.
8 Ekert PG, Silke J, Vaux DL. Caspas-3 inhibitors. Cell Death Differ 1999; 6:1081-1086.
9 Patel T, Gores G. Apoptosis and hepatobiliary disease Hepatology, 1995 , 21:1725-1741
10 Ledda Columbano GM, Coni P,Curto M, et al . Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Patho1, 1991, 139(5) :1099-1109
11 Laddar Columbano GM,Coni P,Faa G, et a1. Rapid induction of apoptosis in rat liver by cycloheximide. Am J Patho1,1992, 140(3) :545-549.
12 Kimura K, Yamamoto M. Modification of the alternative splicing process of testosterone-repressed prostate message-2( TRPM2) gene by protein synthesis inhibitors and heat shock treatment .Biochim Biophys Acta,1996,1307(1):83-88
13 Cohen GM, Sun XM, Snowden RT, et a1. Key morphological features of apoptosis may occure in the absence of internucleosomal DNA fragmentation. Bioch me J,1992,286:331-334
14 W ijsm an JH, Jonker PR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in sita end-labeling off ragemented DNA J histochem cytochem,1993, 41:7
15 Gavrieli Y, Sherm um Y, Shm ael A, et al. Idention of program med cell death in sita via specific labeling of nuclear DNA fragmentation J cell Biol, 1992, 199: 493
16 Teracla T, Nakanum a Y, Detection of apoptosis and expression of apoptosis-related protein during human intrahepatic duct development. Am J pathol, 1995, 146: 67
17 Esolen L M,Sukw P, Jm arle H,et al. Apoptosis as a cause of death in meases virus-infected cells. J Virology, 1995, 169(6):3955-3958
18 Sgonc R, Wick G. Methods for the detection of apoptosis. Int Arch Allergy mmunol,1994;105:327-328
19 Dolzhanskiy A, Basch RS. Flow cytometric determination of apoptosis in halt nogeneous cell populations J Immunol Meth,1995;180:131-140
20 DeZhong L, YouXin J, Hua FI, et al, Preparation and identification of activity of anti-HPV-6b/l 1E 1 universal ribozyme-Rzl 198 in vitro. Asian Journal of Andrology 1999; 1: 195-201.
21 Uhlenbeck OC. A small catalytic oligoribonucleotide. Nature 1987;328:569-600.
22 Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. J Virol, 1997, 71: 1739-1746.
23 Phylaetou LA, Kilpatrick Mw, Wood MI. Ribozyraes as therapeutic tools for genetic disease. Hum Mol Genet, 1998; 7(10): 1649-1653.
24 O rter A O and Janicke R U. Emerging roles of easpase-3 in apoptosis. Cell Death Differ, 1999, 6:99-104
25 Y. Du, R.C. Dodei, K.R. Bales, R. Jemmerson, E. Hamilton-Byrd, and S.M.Involvement of a caspase-3-1ike cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons, J. Neurochem 69 (1997) 1382-1388.
26 R. Klara, Birikh, A. Paul, HEATON and E. Fritz, The structure, function and application of the
hammerhead ribozyme, Eur. J. Biochem. 245 (1997)1-16.
27 K. Kuida, T. S. Zheng, S. Na, CY. Kuan, D. Yang, H. Karasuyama, P. Rakie and R.A. Flavell, Decreased apoptosis in the brain and premature lethality in CPP32-dcficient mice, Nature 384 (1996) 368-372.
28 S.A. Loddick, A. MacKenzie, and N.J. RothwcU, An ICE inhibitor, z-CAD-DCB attenuates ischaemic brain damage in the rat, Neuroreport. 9 (1996) 1465-1468.
29 S.J. Martin, D.R. Green, Protease activation during apoptosis: death by a thousand cuts7 Cell 82 (1995) 349-352.
30 J.C. Martinou and R. Sadoa , ICE-like proteases execute the neuronal death program, Curr. Opin. Neurobiol. 6 (1996) 609-614.
31 J.C. Mayo, R.M. Sainz, I. Antolin, C. Rodriguez, Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage, Brain Res. 818 (1999) 221-227.
32 N.J. McCarthy, L.L. Rubin, and K.L. Philpott, Involvement of caspases in sympathetic neuron apoptosis, J. Cell Sci. l 10 (1997) 2165-2173.
33 Tanaka M, Sawada M , Miura M, el al. Insulin like growth factor l analogue prevents apoptosis mediated through an interleukin beta converting enzyme (caspase1) like protease of cerebellar external granular layer nuruns: developmental stage-specific mechanisms of neuromal cell death. Neuroscience, 1998,84( 1 ) :89-100
34 Reed JC. Double identity fox proteins of the Bcl-2 family. Nature ,1 997,387 :773-776
35 Leung LK, Wang TT . Differential effects of chemotherapeutic agents on the Bcl-2/ Bax apoptosis pathway inhuman breast cancer cell line MCF Breast Cancer Res Treat ,1999 ,55 :73-83
36 Gibson LF,Fortney J, Magro G,et al. Regulation of Bax and Bcl-2 expression in breast cancer cells by chemotherapy. Breast Cancer Res Treat ,1999 ,55 :107-117
37 Nakata B,Muguru ma K, Hirakawa K, et al . Predictive value of Bcl-2 and Bax protein expression for the motherapeutic effect in gastric cancer. On cology ,1998 ,55 :543-547
38 Singleton JR, Dixit VA,Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins . J Biol Chem,1996,271 :31791-31794
39 Guo YS,Jin GF,Houston CW, et al. Insulin-like growth factor promotes multidrug resistance in MCLM colon cancer cells . J Cell physicol,1998,175:141-148
1.刘平,赵志泉,张小勇等。人胃癌组织块裸鼠原位移植/转移模型的建立。肿瘤防治与研究,2001:28:15-16。
2 Weidner N. Intratumor microvessel density as prognostic factor in cancen Am J Pathol, 1995, 147:9-13.
3 Valentinis B, Baserga R. IGFI receptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
4 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ]. Cancer Res, 2002 , 62 (10) :2942 -2950.
5 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis,tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995,55(17) :3739 -3741.
6 Rubini M,Hongo A,D,Ambrosio C,et al.The IGFI receptor in mitogenesis and transformation of mouse embryo cells:role of receptor number[J].Exp Cell Res,1997,230(2):284-292.
1 LeRoith D, wemer H, Beimer-Johonson, et al. Molecular and celluller aspects of the insulin-like growth factor 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
2 Humbel RE.Insulin-like growth factor l and 2[J].Eur J Biochem,1990,190(3):445-462.
3 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
4 Valentinis B, Baserga R. IGFI receptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
5 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ].
Cancer Res, 2002 , 62 (10) :2942 -2950.
6 Blakesley VA, Koval AP, Stannard BS,et al. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth [ J ] . J Biol Chem, 1998, 273 ( 29 ):18411 - 18422.
7 Baserga R. The insulin like growth factor 1 receptor: A Key to Tumor Growth [ J ]. Cancer Research, 1995, 55(2) :249 -252.
8 Le Roith D, weer H, Beimer Johonson, et al. Molecular and cellullar aspects of the insulin-like growth factor 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
9 Russell WE, Van Wyk J J, Pledger W J,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
10 Dal1e S , IMMaura , Rose DW , et al . Insulin induces heterologous desensutuzation of G-protein-coupled receptor and insulin like growth factor 1 signaling by down regulating bets-arrestin-1 [J].MOL Cell Biol,2002,22(17):6272—6285.
11 Morriohe A,DeAngelis T,Baserga R.Failure of the bovine papillomavirus to transform mouse emlbryo fibroblasts with a targeted disruption of the insulin-like growth factor 1 receptor gene [J] ,1995,69(9):5300-5303.
12 Navarro M,Barenton B,Garandel V,et al. insulin like growth factor I(IGFI)receptor over expression abo1ishes the IGF requirement for differetiation and induces a ligand -dependent transformed phenotype in C2 inducible myoblasts [J].Endocrimology,1997,138(12):5210-5219.
13 Desai BJ.Crmber HE. Anti-apoptotic actions of cytokines in mammalian cells.Proc Soe Exp Biol Med,1999.221〔1〕:1-13
14 Harrington EA,Bennett MR, Fanidi A.et al. c-myc induced apoptosis in fibroblast is inhibited by specific cytokines. EMBO J, 1994, 13( 14):3286-3295
15 van Golen CM,Feldman EL. Insulin-like growth factor 1 is the key growth factor in serum that protects neuroblastma cells from hyperosnraic induced apoptosis J Cell Physiol,2000,182:24-32
16 Buerke M, Mumhara T, Skurk C, el M. Cardioprotective effect of insulin like growth factor 1 in myocardial ischemia followed by peffnsion. Proc Nad Acad Sci USA, 1995,92 ( 17 ): 8031-8035
17 Hagae A, Hicks DJ, Bracey TS, et al. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factor protect against c-myc independent apoptosis. Br J Chem, 1997,75(?) :960-968
18 Varro M,Baserga R.limited redundancy of survival signals from the type 1 insulin-like growth factors receptor[J];Endoerinology 2001,142(3):1073—1081.
19 Peretz S, Kim C, Rockwell S, et al. IGFI receptor expression protects against micro environmental stress found in the solid tumor [ J ] .Radiat Res, 2002 ,158(2) :174- 180.
20 Macaulay VM, Salisbury A J, Bohula EA, et al. Down regulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase [ J ]. Ontogene ,2001 ,20 (30) :4029 - 4040.
21 Sun HZ, Wu SF, Tu ZH, et al. Blockage of IGFI R signaling sensitizes urinary bladder cancer cells to mitomy-cin- mediated cytotoxicitv [ J ] Cell Res, 2001 ,11 (2) :107-115.
22 Ellis MJ, Jenkins S, Hanfeh J, el al. Insulin-like growth factors in human breast cancer [ J ]. Breast Cancer Res Treat, 1998, 52 ( 1-3): 175 -184.
23 Liu X, Turbyville T, Fritz A, et al. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice [ J ]. Cancer Res, 1998,58(23) : 5432 -5438.
24 Valentinis, Morriore A, Perazzi F,etal. Antiapoptotic signaling of the IGFI receptor in fibroblasts following loss of matrix adhesion[J] 0ncogene,1999,18(10):1827-1836.
25 Arro M,Baserga R.limited redundancy of survival signals from the type 1 insulin-like growth factors receptor[J];Endoerinology 2001,142(3):1073—1081.
26 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis, tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995,55(17) :3739 -3741.
27 Rubini M, Hongo A, Dambrosio C, etal. The 1GF-l receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number [ J ]. Exp.Cell Res, 1997, 230 (2): 284 -292.
28 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis,tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995,55(17) :3739 -3741.
29 Rubini M,Hongo A,D,Ambrosio C,et al.The IGFI receptor in mitogenesis and transformation of mouse embryo cells:role of receptor number[J].Exp Cell Res,1997,230(2):284—292.
30 Parrizas M,Saltiel AR, Le Roith D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Btol Chem, 1997,272( 1 ): 154-161
31 Bai HZ,Pollman MJ,Inishi Y,et al. Regulation of vascular smooth musle cell apoptois. Modulation of had by a phosphatidylinositol 3-kinase-dependent pathway. Cire Res, 1999,85(3):229-237
32 Matsui T.Li L, del Monte F, et al. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation, 1999, 100( 23 ): 2373-2379
33 Matsuzaki It, Tamatani M. Mitsuda N, et al. Activation of Ak t kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitricoxide in primary hipposampal neutrons. J Neurochem, 1999,73(5):2037-2046
34 Parrizas M,Saltiel AR, LeRoith D.Insalin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Btol Chem, 1997,272( 1 ): 154-161
35 0kubo Y ,Blakesley VA.Stannanl B, et al. Insulin-like growth factor I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem, 1998,273(40): 25961-25966
36 Pugazhenthi S,Miller E,Sable C,et a].Insulin-like growth factor-I induces Bcl-2 promoter through the transcrption factor cAMP-response element binding protein. J Biol Chem, 1999,274(39) :27529 -27535
37 Rosse T, Olivier R, Monney L. et al. Bcl-2 prolongs cell survival after Bax induced celease of cytochorme c. Nature,1998,391(6666) :496-499
38 Cheng EH, Kirsch DG, Clem RI,et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science, 1997,278 ( 5345 ): 1966-1968
39 Kulik G,Weber MJ. Akt-dependent and independent survival signaling pathways utilized hy insulin-like growth factor I. Mol Cell Biol, 1998,18( I I ) :6711~6718
40 Parrizas M,LeRoith D. Insulin-like growth factor-I inhibition of apoptosis associated with increased expression of the Bcl-xl, gene product. Endocrlnology. 1997,138(3 ): 1355-1358
41 Wang L. Ma W. Markovich R, et al Regulation of cardiomyocyle apoptotic signaling by insulin-like growth factor 1. Circ Res. 1998,83t(5 ) :516-522
42 Tanaka M, Sawada M , Miura M, el al. Insulin like growth factor l analogue prevents apoptosis mediated through an interleukin beta converting enzyme ( caspase 1 ) like protease of cerebellar external granular layer nuruns: developmental stage-specific mechanisms of neuromal cell death. Neuroscience, 1998,84( 1 ) :89-100
43 Desai BJ.Crmber HE. Anti-apoptotic actions of cytokines in mammalian cells.Proc Soe Exp Biol Med,1999.221〔1〕:1-13
44 Harrington EA,Bennett MR, Fanidi A.et al. c-myc induced apoptosis in fibroblast is inhibited by specific cytokines. EMBO J, 1994, 13( 14):3286-3295
45 van Golen CM,Feldman EL. Insulin-like growth factor 1 is the key growth factor in serum that protects neuroblastma cells from hyperosnraic- induced apoptosis J Cell Physiol,2000,182:24-32
46 Buerke M, Mumhara T, Skurk C, el M. Cardioprotective effect of insulin-like growth factor 1 in
myocardial ischemia followed by peffnsion. Proc Nad Acad Sci USA, 1995,92 ( 17 ): 8031-8035
47 Hagae A, Hicks DJ, Bracey TS, et al. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factor protect against c-myc-independent apoptosis. Br J Chem, 1997,75(6) :960-968
48 Clark RB; Howell A, Anderson E. Type I insulin - like growth factor receptor gene expression in normal human breast tissue treated with oxstrngen and progesterone [J]. Br J Cancer, 1997,75(2) :251-257.
49 Kim SO, Park JG, Lee YI. Increased expression of the insulin-like growth factor I (IGF- I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF- I receptor gene activation by hepatitis B virus X gene product [ J ]. Cancer Res, 1996,56(16) :3831 --3836.
50 Tajinda K, Carroll J, Roberts Jr CT. Regulation of insulin – like growth factor - I receptor promoter activity by wild - type and mutant versions of the WTl tumor suppressor[J ]. Endocrinology, 1999,140:4713--4724.
51 Wemer H, Shalita- chesner M, Abramovitch S, et al. Regulation of the insulin- like growth factor- I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab,2000,71(1 - 2) :315--320.
51 Ohlsson C, Kley N, Wemer H. et al. P53 regulates IGF- I receptor expression and IGF- I induced tyrosine phosphory lation in an osteosarcoma cell line: interaction between P53 and spl [J ].Endocrinology, 1998,139 (3): 1101 - 1107.
52 Gimita L, Gimita A, Brodin B, et al. Increased expression of insulin- like growth factor I receptor in malignant cells expressing aberrant P53: functional impact [ J ]. Cancer Research, 2000,60: 5278 - 5283.
53 Lee YI, Lee S, Das CC, et al. Activation of the insulin – like growth factor II transcription by aflatoxin BI induced P53 mutant 249 is caused by activation of transcription complexes; implications for a gain- of- function during the formation of hepatocellular carcinoma[J ]. Oncogene, 2000,19(33 ): 3717 - 3726.
54 Shen L, Dean NM, Glazer RI. Induction of P53 - dependent, insulin- like growth factor- binding protein- 3 - mediated apoptosis in glioblastoma multiforme cells by a protein kinase calpha antisense oligonucleotide[J]. Mol Pharrnacol, 1999,55(2) :396-402.
55 Misawa A, Hosoi H, Arimoto A, et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells [ J ] . Cancer Res, 2000,60 ( I ) :64-69.
56 Fukuda R, Hirota K, Fan F, et al. IGFI induces HIF-1-mediated VEGF expression that is dependent on MAP kinase and PI-3-kinase signaling in colon cancer cells [ J ] . J Biol Chem, 2002,277(41) :38205 -38211.
57 Tang Y, Zhang D, Fallavollita L, etal. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor [ J ]. Cancer Res,2003 ,63(6) :1166- 1171.
58 Chilov D, Kukk E, Taira S. Genom organization of human and mouse genes for vascular endothelial growth factor [ J ] .J Biol Chem, 1997, 272 ( 40 ):25176-25183.
59 Ishibashi H, Nakagawa K, Onimaru M,et al. SP1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor , and tissue factor and also cell growth and invasion activities [ J ] Cancer Res, 2000,60(22) :6531 -6536.
60 Qin H, Sun Y, Benveniste EN. Transcription factors SPI, SP3, an AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells [J]. J Biol Chem,1999, 274 (41):29130 -29137.
61 Gimita L, Girnita A, Larsson O, etal. Mdm2 -dependent ubiquitination and degradation of the insulin-like growth factor I receptor [ J ]. Proc Natl Acad Sci USA, 2003, 100 (14):8247 -8252.
62 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
63 Aznavoorian S, Murphy AN, Stetler-stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis[J].Cancer,1993,71(4) :1368-1383.
64 Long L, Rubin R, Baserga R, et al.Loss of the Metastatic Phenotype in Murine Carcinoma Ceils Expressing an Antisense RNA to the Insulin-like Growth factor Receptor [J]. Cancer Res, 1995,55(5) :1006 -1009.
65 Lopez T, Hanahan D. Elevated levels of IGFI receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumor genesis [J ].Cancer Cell, 2002, I (4): 339 -353.
66 Bermont L, Lamielle F, Fauconnet S, et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adeno carcinoma cells [ J ]. Int J Cancer, 2000,85(1) :117 - 123.
67 Dunn SE ,Torres JV , Oh JS, et al.Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein kinase [ J ]. Cancer Res,2001 ,61(4) :1367 - 1374.
68 Dunn SE, Ehrlich M, Sharp NJ, etal. A dominant negative mutant of the insulin-like growth factor-I
receptor inhibits the adhesion, invasion, and metastasis of breast cancer[J ]. Cancer Res, I998, 58(15) :3353 -3361.
69 Sachdev D, Li SL, Ha,ell JS, et al.A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mito- genie effects of IGFI [ J ]. Cancer Res, 2003,63 ( 3 ) :627 -635.
70 Camirand A, Lu Y, Pollak M. Co-targeting HER2/ErbB2 and insulin-like growth factor-I receptors causes synergistic inhibition of growth in HER2overexpressing breast cancer cells [ J ].Med Sci Monit, 2002, 8 (12 ):BR521 - 526.
71 Andrews DW, Resnicoff M, Flanders AE, et al. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malgnant astrocytomas [ J ]. J Clin Oncol,2001,19(8) :2189 -2200.
72 Benini S, Manara MC, Baldini N, etal. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells [ J ]. Clin Cancer Res, 2001 , 7 ( 6 ): 1790 -1797.
73 Blum G, Gazit A, Levitzki A. Development of new IGFI receptor kinase inhibitors using catechol mimics [ J ]. Bid Chem, 2003. 17: 278 ( 42 ):40442 -4045
2 Paquet K-J,Koussouris P,1VErcado MA,et al. Limited hepatic resection for selected cirrhotic patients with hepatocellular or cholangiocellular carcinoma :a prospective study[ J ] . Br J Surgrey ,1 991 ,78 :459.
3 France D,Capussotti L,Smadja C,et al . Resection of hepatocellular carcinoma : results in 72 European patients with cirrhosia[ J ] . Gastroenterrology,1990,98:733.
4 LeRoith D, wemer H, Beimer-Johonson, et al. Molecular and cellullar aspects of the insulin-like growth fator 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
5 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
6 Valentinis B, Baserga R. IGFIReceptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
7 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ]. Cancer Res, 2002 , 62 (10) :2942 -2950.
8 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
9 Bermont L, Lamielle F, Fauconnet S,et aL Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adenocarcinoma ceils [ J ]. lnt J Cancer, 2000,85(1) :117 -
123.
10 Dunn SE ,Torres JV , Oh JS, et al.Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein kinase [ J ]. Cancer Res,2001 ,61(4) :1367 - 1374.
11 Dunn SE, Ehrlich M, Sharp NJ, e tal. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer[J ]. Cancer Res,I998,58(15) :3353 -3361.
12 Fire A, et al. Potent and specific genetic interference by double-stranded RNA in Gaenorhabditis elegans. Nature, 1998, 391:806
1 Colleoni M Gaion F, Liessi C; et al. Medical treatment of hepatocellular carcinoma any progress? Tumri 1994;80: 315-26。
2 LeRoith D, wemer H, Beimer-Johonson, et al. Molecular and cellullar aspects of the insulin-like growth fator 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
3 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
4 Valentinis B, Baserga R. IGFI receptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
5 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ]. Cancer Res, 2002 , 62 (10) :2942-2950.
6 Dal1e S, IMMaura, Rose DW , et al . Insulin induces heterologous desensutuzation of G-protein-coupled recpter and insulin like growth factor 1 signaling by downregulating bets-arrestin-1 [J].MOL Cell Biol,2002,22(17):6272—6285.
7 Baserga R. The insulin like growth factor 1 receptor: A Key to Tumor Growth [ J ]. Cancer Research, 1995, 55(2) :249 -252.
8 Le Roith D, weer H, Beimer Johonson, et al. Molecular and cellullar aspects of the insulin-like growth factor 1 receptor [ J ]. Endocr Rev, 1995 ,16(2) :143 -163.
9 Russell WE, Van Wyk J J, Pledger W J,et al. Inhibition of the mitogenic effect of plasma by
amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
10 Dal1e S,I MMaura,Rose DW,et al.Insulin induces heterologous desensutuzation of G-protein-coupled receptor and insulin like growth factor 1 signaling by down regulating bets-arrestin-1 [J].MOL Cell Biol,2002,22(17):6272-6285.
11 Morriohe A,DeAngelis T,Baserga R.Failure of the bovine papilloma virus to transform mouse emlbryo fibroblasts with a targeted disruption of the insulin-like growth factor 1 receptor gene [J] ,1995,69(9):5300-5303.
12 Navarro M,Barenton B,Garandel V,et al. insulin like growth factor I(IGFI)receptor over expression abo1ishes the IGF requirement for differetiation and induces a ligand -dependent transformed phenotype in C2 inducible myoblasts [J].Endocrimology,1997,138(12):5210-5219.
13 Clark RB; Howell A, Anderson E. Type I insulin - like growth factor receptor gene expression in normal human breast tissue treated with oestrngen and progesterone [J]. Br J Cancer, 1997,75(2) :251-257.
14 Wemer H, Shalita- chesner M, Abramovitch S, et al. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab, 2000,71(1 - 2) :315--320.
15 Ohlsson C, Kley N, Wemer H. et al. P53 regulates IGFI receptor expression and IGFI induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between P53 and spl [J ].Endocrinology, 1998,139 (3): 1101 - 1107.
16 Jone JI, Clemmons D. Insulin-like growth factors and their binding proteins: biological actions[ J] . Endocrine Res,1995 ,16:3.
17 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
18 Aznavoorian S, Murphy AN, Stetler stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis[J].Cancer,1993,71(4) :1368- 1383.
1 Fire A,Xu S,Montgomery MK,et al . Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6 669) :806-811
2 Yu J Y, De Ruiter SL,Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[J].Proc Natl Acad Sci U S A,2002,99(9):6 047-6 052
3 Yang D, Buchholz F,Huang Z,et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells[ J]Proc Natl Acad Sci U S A,2002,99(15) :9 942-9 947
4 Castanotto D, Li H,Rossi JJ. Functional siRNA expression from transfected PCR products[ J] . RNA,2002, 8( 11):1 454
5 Sui G,Soohoo C,Affarel B, et a1. A DNA vector based RNAi,technology to suppress gene expression in mammalian cells[ J] . Proc Natl Acad Sci U S A,2002 ,99( 8) :5 515-5 520。
6 Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by SiRNA in mammalian cells. Proc Natl Acad Sci U S A 2002;99(3):1443-8
7 Yang SH,Tutton S, Yoon K. Specific Double-Stranded RNA Interference in Undifferentiated Mouse Embryonic Stem Cells. Molecular and Cellular Biology. 2001; 21: 7807-7816
8 Xia HB,Mao QW, Paulson HL,Davidson BL. SiRNA mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002; 20:1006-1010
1 Wang D,Jing N,Lin Q. Stearylamine liposome as a new efficient reagent fox DNA transfection of eukaryotic cells .Biochem Biophy Res Co m mu,1996,226(2):450-455
2 Jaaskelainen 1, M onkkonen J, U rttiA. Oligonucleotide cationicliposome interaction. A physicochem ical study [J] Biochim Biaphus Acta, 1994, 1195(l):115-123。
3 Stamatutos L et al. Interactions of cationic lipid vesicles with negatively charged phosphollpld vesicles and biology membranes[J]Biochemistry ,1 988 ,27 :3917-3925
4 Fashnan SJ, Tousigant JD, I Aason M1, et al. Optimivation of fonnulatians and conditions for the aerosol delivery of functional cationic lipid: DNA cotnlexes. Hum Gene ner,1997;8:313-322
5 Felgner PL. Improvements in cationic liposomes for in vivo gene transfer. Hum Gene'Iher, 1996;7:
1791-1793
6 Weber M,M oller K, W elzeck M,et al. Short technical reports Effects of lip opolysaccharide on transfection efficiency in eukaryotic cells[ J]. B iotechniques, 1995, 19(6): 930-940.
7 Mac Gregor G. Optimizxing of electroporation using reporter genes. In Chang DC·Chassy BM·Saunders JAand Sowers AE (Eds). Academic Press Guide to Electroporation and Electrofusion. Academic Press.San Diego. 1992.P. 465-470.
8 J N de Wit. Structure, function and application of lactoperoxidase in natural antimicrobial system E[J].Netherlands Milk &, Dairy Journal, 1996,50:227-244
9 TEKIE W,ASTUMIAN R D,CHOCK P B .Sleective and asymmetric molecular transport across electroprorated cell membrance[J].Pore Natl Acad Sci USA. 1994 ,91 :115.
10 VAN D H,OFF MJ B,CHRISTOFFELS V M, et al .Electrotransfection with" intracellular" buffer[J].Mthods in molecular biology.1995;48 :185-97.
11 Spencer S C.Electroporation technique of DNA transfection. Applied Biochemistry and Biotechnology,1993,42(1):75-82
12 Chalfie M,Tu Y,Euskirchen G,et al. Green fluorescent protein as a marker fox gene expression[J] . Science ,1 994 ,263 :802-805
1 Fire A,Xu S,Montgomery Mc et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans,Nature,1998,391:806-811.
2 NICHOLDNR H,NICHOLDN A W.Molecular characterization Of a mouse cDNA encoding Dicer,a ribonuclease Ⅲ ortholog involved in RNA interference[J].Mann Genome,2002,13(2);67-73.
3 ELBASHIR S M,HARBORTH J,WEBER K,et a1.Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
4 SABINE B. Antisense 2 RNA regulation and RNA interference [J] . Biochemica et Biophysica Acta , 2002 ,1575:15-25.
5 SUI G,SOOHOO C ,AFFAIR E B ,et al. A DNA vector2 based RNAi technology to suppress gene expression in mammalian cells[J ] . Genetics , 2002 , 99(8),5515--5520.
6 ELBASHIR S M,HARBORTH J,WEBER K,et a1. Analysis Of gene function in somatic mammalian cells using small interfering RNAs[J].Methods,2002,(26),199-213
7 SlJEN T, FLEENOR J ,SIMMER F ,et al. On the role of RNA Amplification in dsRNA2 triggered gene silencing[J]. Cell ,2001 ,107(4) ,465-476.
8 LIPARDI C ,WEI Q , PATERSON B M. RNAi .as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNA[J]. Cell , 2001 , 107 (3) :297-- 307.
9 Ngo H ,Tschudi C , Gull K, et al. Double 2 stranded RNA induces mRNA degradation in Trypanosoma brucci. Proc Natl Acad Sci USA ,1998 ,95 (25) :14687-14692.
10 Montgomery MK, Xu S , Fire A. RNA as a target of double stranded RNA mediated genetic interference in Caeanorhabditis elegans. Proc Natl Aced Sci USA ,1998 , 95 (25) :15502--15507.
11 Har Dorth J , Elbashir SM , Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interferingRNAs. J Cell Sci , 2001 , 114 :4557--4565.
12 Yang D , Lu H , Erickson JW,Evidence that processed small dsRNAs may mediate sequence2specific mRNA degradation duringRNAi in Drosophila embryos. Curr Biol , 2000 , 10 (19) : 1191--1200.
13 Sabine B. Antisense RNA regulation and RNA interference. Biochem Biophys Acta , 2002 ,1575 (123) :15225.
14 Gan L , Anton KE , Masterson BA , et al. Specific interference with gene expression and gene function mediated by long double stranded RNA in neural cells. J, 2000 , 9 (18) : 1198--1208.
1 Resnicoff M.Antitum ors effects elicited by antisense-mediated down regulation of the insulin-like grow th factor I receptor. Int J Mol Med,1998, 1(5):883-888.
2 Jones JI,Clemmons DR. Insuline like growth factors and their binding proteins : biological actions( Review) [ J ].Endocr Rev ,1 995 ,16(1):3-33.
3 Chihara K,Sugimoto T.The action of GH/IGF-1/IGF-BP in osteobtasts and osteoclasts[ J] . Horm Res,1997,48:45-49.
4 Wang ZH, Ma JX,Zeng BJ, et al. Correlation of glioma cell regression with inhitition of insulin-like growth factor 1 and insulin-like growth factor-binding protein 2 expression [J] . Neuroendocrinology, 1997 , 66,203.
5 De Meyts P,Urso B,Christoffersen CT, et al .1Vbchanism of insulin and IGF 1 receptor activation and signal transduction specific :receptor dimer cross-linking, bell-shaped curves, and sustained versus transient signaling( Review) [ J ]. Ann NY Acad Sci ,1995, 766( 10) :388-401
6 Khandwala HM, ACutcheon IE,Flyvbjerg A,et al .The effects of insulin like growth factors on tumorigenesis and neoplastic growth[J] Endocr Rev,2000 ,21(3) :215-244.
7 Hellawell GO,Turner GD,Davies DR, et al. Expression of the type 1 insulin like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease[J]。Cancer Res,2002,62( 10) :2942-2950
8 Moschos SJ,Mantzoros CS.The role of the IGF system in cancer: from basic to clinical studies and clinical applications[ J ] . Oncology ,2002, 63(4) :317-332
9 Sell C,Dumenil G,Deveaud C,et al. Effect of a null mutation of the insulin- like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts[ J]Al Cell Biol,1994,14( 6) :3604-3612
10 Weiner H. Dysregulation of the type IGFI Receptor as a paradigm in tumor procession[J] . Mol Cell Endocrinol,1998,141:1-5.
11 lakesley VA, Stannard BS, Kalebic T, et al. Role of the IGFIReceptor in mutagensis and tumor promotion [J] . J Endocrinol,1997, 152: 339-344.
12 Baserga R. The IGF 1 receptor in cancer research[ J].Exp Cell Res 1999 ,263(1) :1-5
13 Reiss K, Ferber A, Travali S ,et al . The protooncogene c- myb increases the expression of insulin like growth factor 1 and insulin like growth factor 1 receptor messenger RNAs by a transcriptional mechanism [J] cancer,Res,1991 ,51(21) :5997-6000
14 Li W, Hyun T,Heller M, et al . Activation of insulin- like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth[ J ] . Cancer res,2000,60(14):3909-3915
15 Long L, Rubin R, Brodt P. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor[ J ] . Exp Cell res,1998,238(1) :116-121
16 Liu X, Turbyville T,FritzA, et a 1. Inhibition of insulin-like growth factor I receptor expression in neuroblastoma cells induces the regression of established tumors in m ice. Cancer Res, 1998, 58(23):5432-5438
17 Alberts B, et al. Molecular Biology of the Cell. 4th ed. New York&London: Carland Publishing Inc, 2002
18 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
1 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
2 Aznavoorian S, Murphy AN, Stetler-stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis [J].Cancer,1993,71(4) :1368
3 Yamamoto Y, Tsutsumi Y, Mayumi T. Molecular design of bioconljugated cell adhesion peptide with a water soluble polymeric modifier for enhancement of an time tastatic effect [J ]. Curr Drug Targets, 2002,3 (2): 123
4 A rihro K, InaiK, Kurara K. Distribution of laminin, type Ⅳ collagen and fibronectin in the invasive component of breast carcinoma. Acta Pathol Jpn Dec,1993; 43: 758
5 Kibbey MC, Grant DS, Kleinman HK. Role of file SIKVAV site of laminin in plarmfion of angiogenesis and tumor growth: All in vivo Matfigel model [J ]. J Natl Cancer Inst ( Bethesda) , 1992; 84:1633- 1638.
6 DeRoock B, Pemfington ME, Stuka TC, et al. Synthetic pepfdes inhibit adhesion of human tumor cells to extracellular matrix proteins [J ]. Cancer Res, 2001 ;61(8): 3308 - 3313.
7 Carlod PS,Norman HA, Parmender P ,et al. Prostate cancer progression,metastasis,and gene expression in transgenis mice . Cancer Res ,1 997 ,57 :900-907.
8 Hee J,Sook B,Ho Y, et al. Anti-invasive activity of solie and correlates with the reduced expression of matrix met all op rote ninnase-9 (MMP-9) in HT-1080 human fibrosarcoma cells. Cancer Res,1996,56:2281-2285.
9 Allgayer H, Babic K, Beyer BC, et al. Prognostic relevance of MMP-2 (72kDconagenase IV) in gastric cancer [J]. Oncology, 1998,55(2):152.
10 Aznavoorian S,Murphy AN, Stetler Stevenson WG, et al. Molecelular suspects of tumor cell invasion and metastasis[ J] . Cancer,1993,71 :1368
11 Dunn SE ,Torres JV , Oh JS, et al. Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein
kinase [ J ]. Cancer Res,2001 ,61(4) :1367 - 1374.
12 Fujihara T,Sawada R, Hirskawa K, et al. Establishment of lymph node metastatic model for human gastric cancer in nude mice and analysis of factors associated with metastasis .Clin Exp Metastasis,1998,16:389-398
13 Yoong KF,Me Nab G,Hubscher SG. Vascular adhesion protein and ICAM-1 support the adhesion of tumor in filtrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J I m munol,1998,160 :3978-3988
14 Albelda S M,Buck CA. Integrins and other cell adhesion molecules. FASEB J,1996 ,17 :71-81
15 Liotta LA, Wewer U, Rao NC et al. Bio chemical mechanisms of to more invasion and metastases. Adv Exp Med Biol,1988 ,233:161
16 Pellegrinl R, Martignone S,Tagliabue E et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinoma. Breast Cancer Res Treat ,1995 ,35:195
17 Marques LA, Franco ELF, Torloni H et al. Independent prognostic value of laminin receptor expression in breast cancer survival. Cancer Res,1990,50:1 870
18 MareelM,B racke M&VanRoy F. Cancer metastasis: negative regulation by an invasion-suppressor complex. Cancer Detect P rev, 1995,19(5):451.
19 Dunn SE, Ehrlich M, Sharp NJ, et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer [J ]. Cancer Res,1998,58(15) :3353 -3361.
20 Hildebrand JD, Schaller MD,Parsons JT,et al. Identification of sequences required for the efficient localization of the focal adhesion kinase,PP 125 FAKpp,to cellular focal adhesions . J Cell Biol , 1995 ,123 :993-1005
21 Schlaepfer DD, Hanks SK, Hunter T, et al. Integrin7mediated signal transduction linked to Ras pathway by 2 binding to focal adhesion kinase . Nature , 1994 ,372 :22-29
22 Hildebrand JD, Schaller MD, Parsons- JT, et al . Paxillin,a tyrosine phosphorylated focal adhesion7associated protein,binds to the carboxyl termination domain of focal adhesion kinase . Mol Biol Cell ,1 995 ,6 :637-647
23 Frisch S M, Vuori K, Ruoslahti E,et al . Control of adhesion- dependent cell survival by focal adhesion kinase. J Cell Bio1,1996, 134:293-299
24 Owens LV, Xu LH,Craven RJ, et al 0verxpression of the focal adhesion kinase(p1 25 FAK) in invasive human tumors . Cancer Res ,1 995,55 :2752-2755
1 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis, tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995, 55(17) :3739 -3741.
2 Rubini M, Hongo A, Dambrosio C, etal. The IGF-l receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number [ J ]. Exp.Cell Res, 1997, 230 (2): 284 -292.
3 Resnicoff M, Burgaud JL, Rotman HL , et al. Correlation between apoptosis, tumorigeneisis, and levels of insulin like growth factor 1 receptors [J ]. Cancer Res,1995,55(17) :3739 -3741.
4 韩锐主编。抗癌药物研究与实验技术。人民卫生出版社 1997
5 Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J cell Biol, 1992, 119(3):493-501
6 CarbonariM,CibatiM,Fiorilli M,et al. Measurement of apoptotic cells in peripheral blood. Cytometry, 1995, 22(3):161-167
7.Inayat-Hussain, Couet SHC, Cohen GM, et al. Processing/activation of CPP32-1ike proteases is involved in transforming growth factor is induced apoptosis in rat hepatocytes. Hepatology 1997; 25:1516-1523.
8 Ekert PG, Silke J, Vaux DL. Caspas-3 inhibitors. Cell Death Differ 1999; 6:1081-1086.
9 Patel T, Gores G. Apoptosis and hepatobiliary disease Hepatology, 1995 , 21:1725-1741
10 Ledda Columbano GM, Coni P,Curto M, et al . Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Patho1, 1991, 139(5) :1099-1109
11 Laddar Columbano GM,Coni P,Faa G, et a1. Rapid induction of apoptosis in rat liver by cycloheximide. Am J Patho1,1992, 140(3) :545-549.
12 Kimura K, Yamamoto M. Modification of the alternative splicing process of testosterone-repressed prostate message-2( TRPM2) gene by protein synthesis inhibitors and heat shock treatment .Biochim Biophys Acta,1996,1307(1):83-88
13 Cohen GM, Sun XM, Snowden RT, et a1. Key morphological features of apoptosis may occure in the absence of internucleosomal DNA fragmentation. Bioch me J,1992,286:331-334
14 W ijsm an JH, Jonker PR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in sita end-labeling off ragemented DNA J histochem cytochem,1993, 41:7
15 Gavrieli Y, Sherm um Y, Shm ael A, et al. Idention of program med cell death in sita via specific labeling of nuclear DNA fragmentation J cell Biol, 1992, 199: 493
16 Teracla T, Nakanum a Y, Detection of apoptosis and expression of apoptosis-related protein during human intrahepatic duct development. Am J pathol, 1995, 146: 67
17 Esolen L M,Sukw P, Jm arle H,et al. Apoptosis as a cause of death in meases virus-infected cells. J Virology, 1995, 169(6):3955-3958
18 Sgonc R, Wick G. Methods for the detection of apoptosis. Int Arch Allergy mmunol,1994;105:327-328
19 Dolzhanskiy A, Basch RS. Flow cytometric determination of apoptosis in halt nogeneous cell populations J Immunol Meth,1995;180:131-140
20 DeZhong L, YouXin J, Hua FI, et al, Preparation and identification of activity of anti-HPV-6b/l 1E 1 universal ribozyme-Rzl 198 in vitro. Asian Journal of Andrology 1999; 1: 195-201.
21 Uhlenbeck OC. A small catalytic oligoribonucleotide. Nature 1987;328:569-600.
22 Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. J Virol, 1997, 71: 1739-1746.
23 Phylaetou LA, Kilpatrick Mw, Wood MI. Ribozyraes as therapeutic tools for genetic disease. Hum Mol Genet, 1998; 7(10): 1649-1653.
24 O rter A O and Janicke R U. Emerging roles of easpase-3 in apoptosis. Cell Death Differ, 1999, 6:99-104
25 Y. Du, R.C. Dodei, K.R. Bales, R. Jemmerson, E. Hamilton-Byrd, and S.M.Involvement of a caspase-3-1ike cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons, J. Neurochem 69 (1997) 1382-1388.
26 R. Klara, Birikh, A. Paul, HEATON and E. Fritz, The structure, function and application of the
hammerhead ribozyme, Eur. J. Biochem. 245 (1997)1-16.
27 K. Kuida, T. S. Zheng, S. Na, CY. Kuan, D. Yang, H. Karasuyama, P. Rakie and R.A. Flavell, Decreased apoptosis in the brain and premature lethality in CPP32-dcficient mice, Nature 384 (1996) 368-372.
28 S.A. Loddick, A. MacKenzie, and N.J. RothwcU, An ICE inhibitor, z-CAD-DCB attenuates ischaemic brain damage in the rat, Neuroreport. 9 (1996) 1465-1468.
29 S.J. Martin, D.R. Green, Protease activation during apoptosis: death by a thousand cuts7 Cell 82 (1995) 349-352.
30 J.C. Martinou and R. Sadoa , ICE-like proteases execute the neuronal death program, Curr. Opin. Neurobiol. 6 (1996) 609-614.
31 J.C. Mayo, R.M. Sainz, I. Antolin, C. Rodriguez, Ultrastructural confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage, Brain Res. 818 (1999) 221-227.
32 N.J. McCarthy, L.L. Rubin, and K.L. Philpott, Involvement of caspases in sympathetic neuron apoptosis, J. Cell Sci. l 10 (1997) 2165-2173.
33 Tanaka M, Sawada M , Miura M, el al. Insulin like growth factor l analogue prevents apoptosis mediated through an interleukin beta converting enzyme (caspase1) like protease of cerebellar external granular layer nuruns: developmental stage-specific mechanisms of neuromal cell death. Neuroscience, 1998,84( 1 ) :89-100
34 Reed JC. Double identity fox proteins of the Bcl-2 family. Nature ,1 997,387 :773-776
35 Leung LK, Wang TT . Differential effects of chemotherapeutic agents on the Bcl-2/ Bax apoptosis pathway inhuman breast cancer cell line MCF Breast Cancer Res Treat ,1999 ,55 :73-83
36 Gibson LF,Fortney J, Magro G,et al. Regulation of Bax and Bcl-2 expression in breast cancer cells by chemotherapy. Breast Cancer Res Treat ,1999 ,55 :107-117
37 Nakata B,Muguru ma K, Hirakawa K, et al . Predictive value of Bcl-2 and Bax protein expression for the motherapeutic effect in gastric cancer. On cology ,1998 ,55 :543-547
38 Singleton JR, Dixit VA,Feldman EL. Type I insulin-like growth factor receptor activation regulates apoptotic proteins . J Biol Chem,1996,271 :31791-31794
39 Guo YS,Jin GF,Houston CW, et al. Insulin-like growth factor promotes multidrug resistance in MCLM colon cancer cells . J Cell physicol,1998,175:141-148
1.刘平,赵志泉,张小勇等。人胃癌组织块裸鼠原位移植/转移模型的建立。肿瘤防治与研究,2001:28:15-16。
2 Weidner N. Intratumor microvessel density as prognostic factor in cancen Am J Pathol, 1995, 147:9-13.
3 Valentinis B, Baserga R. IGFI receptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
4 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ]. Cancer Res, 2002 , 62 (10) :2942 -2950.
5 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis,tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995,55(17) :3739 -3741.
6 Rubini M,Hongo A,D,Ambrosio C,et al.The IGFI receptor in mitogenesis and transformation of mouse embryo cells:role of receptor number[J].Exp Cell Res,1997,230(2):284-292.
1 LeRoith D, wemer H, Beimer-Johonson, et al. Molecular and celluller aspects of the insulin-like growth factor 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
2 Humbel RE.Insulin-like growth factor l and 2[J].Eur J Biochem,1990,190(3):445-462.
3 Russell WE, Van Wyk JJ, Pledger WJ,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
4 Valentinis B, Baserga R. IGFI receptor signalling in transformation and differentiation [ J ] . Mol Pathol, 2001 , 54(3):133 -137.
5 Hellawell GO, Turner GD, Davies DR, et al. Expression of the type insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease [ J ].
Cancer Res, 2002 , 62 (10) :2942 -2950.
6 Blakesley VA, Koval AP, Stannard BS,et al. Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth [ J ] . J Biol Chem, 1998, 273 ( 29 ):18411 - 18422.
7 Baserga R. The insulin like growth factor 1 receptor: A Key to Tumor Growth [ J ]. Cancer Research, 1995, 55(2) :249 -252.
8 Le Roith D, weer H, Beimer Johonson, et al. Molecular and cellullar aspects of the insulin-like growth factor 1 receptor [ J ]. Endocr Rev, 1995 , 16(2) :143 -163.
9 Russell WE, Van Wyk J J, Pledger W J,et al. Inhibition of the mitogenic effect of plasma by amonoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA , 1984,81 (8) :2389 -2393.
10 Dal1e S , IMMaura , Rose DW , et al . Insulin induces heterologous desensutuzation of G-protein-coupled receptor and insulin like growth factor 1 signaling by down regulating bets-arrestin-1 [J].MOL Cell Biol,2002,22(17):6272—6285.
11 Morriohe A,DeAngelis T,Baserga R.Failure of the bovine papillomavirus to transform mouse emlbryo fibroblasts with a targeted disruption of the insulin-like growth factor 1 receptor gene [J] ,1995,69(9):5300-5303.
12 Navarro M,Barenton B,Garandel V,et al. insulin like growth factor I(IGFI)receptor over expression abo1ishes the IGF requirement for differetiation and induces a ligand -dependent transformed phenotype in C2 inducible myoblasts [J].Endocrimology,1997,138(12):5210-5219.
13 Desai BJ.Crmber HE. Anti-apoptotic actions of cytokines in mammalian cells.Proc Soe Exp Biol Med,1999.221〔1〕:1-13
14 Harrington EA,Bennett MR, Fanidi A.et al. c-myc induced apoptosis in fibroblast is inhibited by specific cytokines. EMBO J, 1994, 13( 14):3286-3295
15 van Golen CM,Feldman EL. Insulin-like growth factor 1 is the key growth factor in serum that protects neuroblastma cells from hyperosnraic induced apoptosis J Cell Physiol,2000,182:24-32
16 Buerke M, Mumhara T, Skurk C, el M. Cardioprotective effect of insulin like growth factor 1 in myocardial ischemia followed by peffnsion. Proc Nad Acad Sci USA, 1995,92 ( 17 ): 8031-8035
17 Hagae A, Hicks DJ, Bracey TS, et al. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factor protect against c-myc independent apoptosis. Br J Chem, 1997,75(?) :960-968
18 Varro M,Baserga R.limited redundancy of survival signals from the type 1 insulin-like growth factors receptor[J];Endoerinology 2001,142(3):1073—1081.
19 Peretz S, Kim C, Rockwell S, et al. IGFI receptor expression protects against micro environmental stress found in the solid tumor [ J ] .Radiat Res, 2002 ,158(2) :174- 180.
20 Macaulay VM, Salisbury A J, Bohula EA, et al. Down regulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase [ J ]. Ontogene ,2001 ,20 (30) :4029 - 4040.
21 Sun HZ, Wu SF, Tu ZH, et al. Blockage of IGFI R signaling sensitizes urinary bladder cancer cells to mitomy-cin- mediated cytotoxicitv [ J ] Cell Res, 2001 ,11 (2) :107-115.
22 Ellis MJ, Jenkins S, Hanfeh J, el al. Insulin-like growth factors in human breast cancer [ J ]. Breast Cancer Res Treat, 1998, 52 ( 1-3): 175 -184.
23 Liu X, Turbyville T, Fritz A, et al. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice [ J ]. Cancer Res, 1998,58(23) : 5432 -5438.
24 Valentinis, Morriore A, Perazzi F,etal. Antiapoptotic signaling of the IGFI receptor in fibroblasts following loss of matrix adhesion[J] 0ncogene,1999,18(10):1827-1836.
25 Arro M,Baserga R.limited redundancy of survival signals from the type 1 insulin-like growth factors receptor[J];Endoerinology 2001,142(3):1073—1081.
26 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis, tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995,55(17) :3739 -3741.
27 Rubini M, Hongo A, Dambrosio C, etal. The 1GF-l receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number [ J ]. Exp.Cell Res, 1997, 230 (2): 284 -292.
28 Resnicoff M, Burgaud JL, Rotman HL, et al. Correlation between apoptosis,tumorigeneisis, and levels of insulin like growth factor 1 receptors [ J ]. Cancer Res,1995,55(17) :3739 -3741.
29 Rubini M,Hongo A,D,Ambrosio C,et al.The IGFI receptor in mitogenesis and transformation of mouse embryo cells:role of receptor number[J].Exp Cell Res,1997,230(2):284—292.
30 Parrizas M,Saltiel AR, Le Roith D. Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Btol Chem, 1997,272( 1 ): 154-161
31 Bai HZ,Pollman MJ,Inishi Y,et al. Regulation of vascular smooth musle cell apoptois. Modulation of had by a phosphatidylinositol 3-kinase-dependent pathway. Cire Res, 1999,85(3):229-237
32 Matsui T.Li L, del Monte F, et al. Adenoviral gene transfer of activated phosphatidylinositol 3'-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation, 1999, 100( 23 ): 2373-2379
33 Matsuzaki It, Tamatani M. Mitsuda N, et al. Activation of Ak t kinase inhibits apoptosis and changes in Bcl-2 and Bax expression induced by nitricoxide in primary hipposampal neutrons. J Neurochem, 1999,73(5):2037-2046
34 Parrizas M,Saltiel AR, LeRoith D.Insalin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways. J Btol Chem, 1997,272( 1 ): 154-161
35 0kubo Y ,Blakesley VA.Stannanl B, et al. Insulin-like growth factor I inhibits the stress-activated protein kinase/c-Jun N-terminal kinase. J Biol Chem, 1998,273(40): 25961-25966
36 Pugazhenthi S,Miller E,Sable C,et a].Insulin-like growth factor-I induces Bcl-2 promoter through the transcrption factor cAMP-response element binding protein. J Biol Chem, 1999,274(39) :27529 -27535
37 Rosse T, Olivier R, Monney L. et al. Bcl-2 prolongs cell survival after Bax induced celease of cytochorme c. Nature,1998,391(6666) :496-499
38 Cheng EH, Kirsch DG, Clem RI,et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science, 1997,278 ( 5345 ): 1966-1968
39 Kulik G,Weber MJ. Akt-dependent and independent survival signaling pathways utilized hy insulin-like growth factor I. Mol Cell Biol, 1998,18( I I ) :6711~6718
40 Parrizas M,LeRoith D. Insulin-like growth factor-I inhibition of apoptosis associated with increased expression of the Bcl-xl, gene product. Endocrlnology. 1997,138(3 ): 1355-1358
41 Wang L. Ma W. Markovich R, et al Regulation of cardiomyocyle apoptotic signaling by insulin-like growth factor 1. Circ Res. 1998,83t(5 ) :516-522
42 Tanaka M, Sawada M , Miura M, el al. Insulin like growth factor l analogue prevents apoptosis mediated through an interleukin beta converting enzyme ( caspase 1 ) like protease of cerebellar external granular layer nuruns: developmental stage-specific mechanisms of neuromal cell death. Neuroscience, 1998,84( 1 ) :89-100
43 Desai BJ.Crmber HE. Anti-apoptotic actions of cytokines in mammalian cells.Proc Soe Exp Biol Med,1999.221〔1〕:1-13
44 Harrington EA,Bennett MR, Fanidi A.et al. c-myc induced apoptosis in fibroblast is inhibited by specific cytokines. EMBO J, 1994, 13( 14):3286-3295
45 van Golen CM,Feldman EL. Insulin-like growth factor 1 is the key growth factor in serum that protects neuroblastma cells from hyperosnraic- induced apoptosis J Cell Physiol,2000,182:24-32
46 Buerke M, Mumhara T, Skurk C, el M. Cardioprotective effect of insulin-like growth factor 1 in
myocardial ischemia followed by peffnsion. Proc Nad Acad Sci USA, 1995,92 ( 17 ): 8031-8035
47 Hagae A, Hicks DJ, Bracey TS, et al. Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factor protect against c-myc-independent apoptosis. Br J Chem, 1997,75(6) :960-968
48 Clark RB; Howell A, Anderson E. Type I insulin - like growth factor receptor gene expression in normal human breast tissue treated with oxstrngen and progesterone [J]. Br J Cancer, 1997,75(2) :251-257.
49 Kim SO, Park JG, Lee YI. Increased expression of the insulin-like growth factor I (IGF- I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF- I receptor gene activation by hepatitis B virus X gene product [ J ]. Cancer Res, 1996,56(16) :3831 --3836.
50 Tajinda K, Carroll J, Roberts Jr CT. Regulation of insulin – like growth factor - I receptor promoter activity by wild - type and mutant versions of the WTl tumor suppressor[J ]. Endocrinology, 1999,140:4713--4724.
51 Wemer H, Shalita- chesner M, Abramovitch S, et al. Regulation of the insulin- like growth factor- I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab,2000,71(1 - 2) :315--320.
51 Ohlsson C, Kley N, Wemer H. et al. P53 regulates IGF- I receptor expression and IGF- I induced tyrosine phosphory lation in an osteosarcoma cell line: interaction between P53 and spl [J ].Endocrinology, 1998,139 (3): 1101 - 1107.
52 Gimita L, Gimita A, Brodin B, et al. Increased expression of insulin- like growth factor I receptor in malignant cells expressing aberrant P53: functional impact [ J ]. Cancer Research, 2000,60: 5278 - 5283.
53 Lee YI, Lee S, Das CC, et al. Activation of the insulin – like growth factor II transcription by aflatoxin BI induced P53 mutant 249 is caused by activation of transcription complexes; implications for a gain- of- function during the formation of hepatocellular carcinoma[J ]. Oncogene, 2000,19(33 ): 3717 - 3726.
54 Shen L, Dean NM, Glazer RI. Induction of P53 - dependent, insulin- like growth factor- binding protein- 3 - mediated apoptosis in glioblastoma multiforme cells by a protein kinase calpha antisense oligonucleotide[J]. Mol Pharrnacol, 1999,55(2) :396-402.
55 Misawa A, Hosoi H, Arimoto A, et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells [ J ] . Cancer Res, 2000,60 ( I ) :64-69.
56 Fukuda R, Hirota K, Fan F, et al. IGFI induces HIF-1-mediated VEGF expression that is dependent on MAP kinase and PI-3-kinase signaling in colon cancer cells [ J ] . J Biol Chem, 2002,277(41) :38205 -38211.
57 Tang Y, Zhang D, Fallavollita L, etal. Vascular endothelial growth factor C expression and lymph node metastasis are regulated by the type I insulin-like growth factor receptor [ J ]. Cancer Res,2003 ,63(6) :1166- 1171.
58 Chilov D, Kukk E, Taira S. Genom organization of human and mouse genes for vascular endothelial growth factor [ J ] .J Biol Chem, 1997, 272 ( 40 ):25176-25183.
59 Ishibashi H, Nakagawa K, Onimaru M,et al. SP1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor , and tissue factor and also cell growth and invasion activities [ J ] Cancer Res, 2000,60(22) :6531 -6536.
60 Qin H, Sun Y, Benveniste EN. Transcription factors SPI, SP3, an AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells [J]. J Biol Chem,1999, 274 (41):29130 -29137.
61 Gimita L, Girnita A, Larsson O, etal. Mdm2 -dependent ubiquitination and degradation of the insulin-like growth factor I receptor [ J ]. Proc Natl Acad Sci USA, 2003, 100 (14):8247 -8252.
62 Yeatman TJ, Nicolson GL. Molecular basis of tumor progression: mechanisms of organ-specific tumor metastasis[ J ].Semin Surg Oncol, 1993,9 ( 3 ) :256- 263.
63 Aznavoorian S, Murphy AN, Stetler-stevenson WG, et al. Molecular aspects of tumor cell invasion and metastasis[J].Cancer,1993,71(4) :1368-1383.
64 Long L, Rubin R, Baserga R, et al.Loss of the Metastatic Phenotype in Murine Carcinoma Ceils Expressing an Antisense RNA to the Insulin-like Growth factor Receptor [J]. Cancer Res, 1995,55(5) :1006 -1009.
65 Lopez T, Hanahan D. Elevated levels of IGFI receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumor genesis [J ].Cancer Cell, 2002, I (4): 339 -353.
66 Bermont L, Lamielle F, Fauconnet S, et al. Regulation of vascular endothelial growth factor expression by insulin-like growth factor-I in endometrial adeno carcinoma cells [ J ]. Int J Cancer, 2000,85(1) :117 - 123.
67 Dunn SE ,Torres JV , Oh JS, et al.Up-regulation of urokinase type plasminogen activator by insulin-like growth factor-I depends upon phosphatidytinositol-3 kinase and mitogen-activated protein kinase [ J ]. Cancer Res,2001 ,61(4) :1367 - 1374.
68 Dunn SE, Ehrlich M, Sharp NJ, etal. A dominant negative mutant of the insulin-like growth factor-I
receptor inhibits the adhesion, invasion, and metastasis of breast cancer[J ]. Cancer Res, I998, 58(15) :3353 -3361.
69 Sachdev D, Li SL, Ha,ell JS, et al.A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mito- genie effects of IGFI [ J ]. Cancer Res, 2003,63 ( 3 ) :627 -635.
70 Camirand A, Lu Y, Pollak M. Co-targeting HER2/ErbB2 and insulin-like growth factor-I receptors causes synergistic inhibition of growth in HER2overexpressing breast cancer cells [ J ].Med Sci Monit, 2002, 8 (12 ):BR521 - 526.
71 Andrews DW, Resnicoff M, Flanders AE, et al. Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malgnant astrocytomas [ J ]. J Clin Oncol,2001,19(8) :2189 -2200.
72 Benini S, Manara MC, Baldini N, etal. Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells [ J ]. Clin Cancer Res, 2001 , 7 ( 6 ): 1790 -1797.
73 Blum G, Gazit A, Levitzki A. Development of new IGFI receptor kinase inhibitors using catechol mimics [ J ]. Bid Chem, 2003. 17: 278 ( 42 ):40442 -4045